Modulakgotla A. Sebe
Johannesburg, GT, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 11, 2025
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial.
Journal: The Lancet. Infectious diseases
Published: December 06, 2024
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial.
Journal: The Lancet. Infectious diseases
Published: December 06, 2024
A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis.
Journal: Trials
Published: September 01, 2022
Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk.
Journal: The Journal of infectious diseases
Published: February 16, 2022
Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial.
Journal: Annals of internal medicine
Published: August 23, 2021
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: March 25, 2021
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
Journal: The New England journal of medicine
Published: March 24, 2021
Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial.
Journal: PloS one
Published: February 04, 2021
HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: April 23, 2020
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial.
Journal: The lancet. HIV
Published: October 31, 2019
Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 26, 2019
Last Updated: 09/26/2026